Published • loading... • Updated
New endometriosis tests set to dramatically speed up diagnosis
Draft guidance would let GPs use two non-invasive tests for suspected endometriosis, with NICE saying they could speed diagnosis and reduce surgery.
- The National Institute for Health and Care Excellence issued draft guidance yesterday recommending Endotest and EndoSure for NHS primary care use, approving the non-invasive tests for a three-year evaluation period.
- Endometriosis affects one in 10 women, yet the All-Party Parliamentary Group survey of more than 10,000 women found over half visited their GP more than 10 times before diagnosis, often misdiagnosed as irritable bowel syndrome.
- Endotest analyzes saliva for microRNAs, whereas EndoSure measures gut electrical signals via abdominal sensor pads, offering non-invasive alternatives when clinical exams or imaging prove normal or inconclusive.
- Consultant gynaecologist Dr. Gail Busby described the tests as a 'game-changer' that could free up surgical slots, while 15-year-old Simran Chavda said the quick test gave her 'concrete evidence' to secure a referral.
- Endometriosis UK CEO Emma Cox stressed that GP education must accompany test availability to ensure prompt access, while NICE determined a third technology, DotEndo, currently lacks sufficient evidence for NHS approval.
Insights by Ground AI
17 Articles
17 Articles
Coverage Details
Total News Sources17
Leaning Left5Leaning Right0Center8Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 38%
C 62%
Factuality
To view factuality data please Upgrade to Premium
